Attenuated virulence of Streptococcus agalactiae deficient in D‐alanyl‐lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells

D‐alanylation of lipoteichoic acid (LTA), allows Gram‐positive bacteria to modulate their surface charge, regulate ligand binding and control the electromechanical properties of the cell wall. In this study, the role of D‐alanyl LTA in the virulence of the extracellular pathogen Streptococcus agalactiae was investigated. We demonstrate that a DltA– isogenic mutant displays an increased susceptibility to host defence peptides such as human defensins and animal‐derived cationic peptides. Accordingly, the mutant strain is more susceptible to killing by mice bone marrow‐derived macrophages and human neutrophils than the wild‐type strain. In addition, the virulence of the DltA– mutant is severely impaired in mouse and neonatal rat models. This mutant was eliminated more rapidly than the wild‐type strain from the lung of three‐week‐old mice inoculated intranasally and, consequently, is unable to induce a pneumonia. Finally, after intravenous injection of three‐week‐old mice, the survival of the DltA– mutant is markedly reduced in the blood in comparison to that of the wild‐type strain. We hypothesize that the decreased virulence of the DltA– mutant is a consequence of its increased susceptibility to cationic antimicrobial peptides and to killing by phagocytes. These results demonstrate that the D‐alanylation of LTA contributes to the virulence of S. agalactiae.

[1]  Carmen Buchrieser,et al.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease , 2002, Molecular microbiology.

[2]  B. Neumeister,et al.  Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. , 2002, The Journal of infectious diseases.

[3]  S. Grinstein,et al.  Determinants of the Phagosomal pH in Neutrophils* , 2002, The Journal of Biological Chemistry.

[4]  F. Fiedler,et al.  Formation of D‐alanyl‐lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes , 2002, Molecular microbiology.

[5]  H. Courtney,et al.  Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci , 2002, Annals of medicine.

[6]  F. Fiedler,et al.  Regulation of d-Alanyl-Lipoteichoic Acid Biosynthesis in Streptococcus agalactiae Involves a Novel Two-Component Regulatory System , 2001, Journal of bacteriology.

[7]  M. Baptista,et al.  Contribution of Mn-Cofactored Superoxide Dismutase (SodA) to the Virulence of Streptococcus agalactiae , 2001, Infection and Immunity.

[8]  Michael Otto,et al.  Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.

[9]  T. Ganz,et al.  Antimicrobial Proteins and Peptides , 2001 .

[10]  Defects in D-alanyl-lipoteichoic acid synthesis in Streptococcus mutans results in acid sensitivity. , 2000, Journal of bacteriology.

[11]  Robert Bals,et al.  Epithelial antimicrobial peptides in host defense against infection , 2000, Respiratory research.

[12]  O. Levy,et al.  Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. , 2000, Blood.

[13]  J. Heitman Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2000 .

[14]  M. Kiriukhin,et al.  Biosynthesis of Lipoteichoic Acid inLactobacillus rhamnosus: Role of DltD ind-Alanylation , 2000, Journal of bacteriology.

[15]  Insertional Inactivation of Genes Responsible for thed-Alanylation of Lipoteichoic Acid inStreptococcus gordonii DL1 (Challis) Affects Intrageneric Coaggregations , 1999, Infection and Immunity.

[16]  H. Kalbacher,et al.  Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.

[17]  V. Bafna,et al.  Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. , 1998, The Journal of clinical investigation.

[18]  A. Schuchat Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.

[19]  P. Berche,et al.  Molecular characterization and expression analysis of the superoxide dismutase gene from Streptococcus agalactiae. , 1997, Gene.

[20]  W. Fischer,et al.  The absence of D-alanine from lipoteichoic acid and wall teichoic acid alters surface charge, enhances autolysis and increases susceptibility to methicillin in Bacillus subtilis. , 1997, Microbiology.

[21]  C. Kozak,et al.  Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.

[22]  M. P. Heaton,et al.  The dlt operon in the biosynthesis of D-alanyl-lipoteichoic acid in Lactobacillus casei. , 1996, Microbial drug resistance.

[23]  M. Perego,et al.  Incorporation of D-Alanine into Lipoteichoic Acid and Wall Teichoic Acid in Bacillus subtilis , 1995, The Journal of Biological Chemistry.

[24]  P. Berche Bacteremia is required for invasion of the murine central nervous system by Listeria monocytogenes. , 1995, Microbial pathogenesis.

[25]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[26]  R. van Furth,et al.  Antimicrobial mechanisms: antimicrobial polypeptides of mononuclear phagocytes. , 1994, Immunology series.

[27]  E. Groisman,et al.  Resistance to host antimicrobial peptides is necessary for Salmonella virulence. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. von Hunolstein,et al.  Lipoteichoic acid and M protein: dual adhesins of group A streptococci. , 1992, Microbial pathogenesis.

[29]  H. Rosen,et al.  Phagocytosis of opsonized oil droplets by neutrophils. Adaptation to a microtiter plate format. , 1991, Journal of immunological methods.

[30]  W. Fischer,et al.  On the basic structure of poly(glycerophosphate) lipoteichoic acids. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[31]  O. Leon,et al.  Adherence of Streptococcus agalactiae to synchronously growing human cell monolayers without lipoteichoic acid involvement , 1988, Infection and immunity.

[32]  W. Fischer Physiology of lipoteichoic acids in bacteria. , 1988, Advances in microbial physiology.

[33]  G. Teti,et al.  Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid , 1987, Infection and immunity.

[34]  I. Maridonneau-Parini,et al.  Identification of distinct activation pathways of the human neutrophil NADPH-oxidase. , 1986, Journal of immunology.

[35]  L. Tomalty,et al.  Experimental meningococcal infection in mice: a model for mucosal invasion , 1986, Infection and immunity.

[36]  T. Nealon,et al.  Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells , 1984, Infection and immunity.

[37]  T. Nealon,et al.  Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease , 1983, Infection and immunity.

[38]  K. Warren,et al.  Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. , 1983, Journal of immunology.

[39]  F. Fiedler,et al.  Alanine ester-containing native lipoteichoic acids do not act as lipoteichoic acid carrier. Isolation, structural and functional characterization. , 1980, The Journal of biological chemistry.

[40]  P. Ferrieri,et al.  Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes , 1980, Infection and immunity.

[41]  K. Boyer,et al.  Group B streptococcal infections. , 2002, Pediatrics in review.

[42]  R. Bortolussi,et al.  Dynamics of Escherichia coli infection and meningitis in infant rats , 1978, Infection and immunity.

[43]  A. Katzenstein,et al.  Pulmonary Changes in Neonatal Sepsis Due to Group B β-Hemolytic Streptococcus: Relation to Hyaline Membrane Disease , 1976 .

[44]  E. Effmann,et al.  A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn. , 1976, The New England journal of medicine.

[45]  A. Katzenstein,et al.  Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease. , 1976, The Journal of infectious diseases.